Creative Medical Technology Holdings, Inc. Debt Conversion, Original Debt, Amount
Creative Medical Technology Holdings, Inc. (CELZ) reported Debt Conversion, Original Debt, Amount of $1.38 million for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-31.
Discontinued › Cash Flow › Financing Activities
us-gaap:DebtConversionOriginalDebtAmount1 · last filed 2023-03-31
- Creative Medical Technology Holdings, Inc. debt conversion, original debt, amount for the quarter ending 2021-12-31 was $1.00, a 100.00% decline year-over-year.
- Creative Medical Technology Holdings, Inc. debt conversion, original debt, amount for the quarter ending 2021-09-30 was $153.98K, a 64.04% decline year-over-year.
- Creative Medical Technology Holdings, Inc. debt conversion, original debt, amount for the quarter ending 2021-06-30 was $341.79K, a 34.19% increase year-over-year.
- Creative Medical Technology Holdings, Inc. debt conversion, original debt, amount for the quarter ending 2021-03-31 was $887.56K, a 153.19% increase year-over-year.
- Creative Medical Technology Holdings, Inc. debt conversion, original debt, amount for fiscal 2021 was $1.38M, a 1.22% increase from fiscal 2020.
- Creative Medical Technology Holdings, Inc. debt conversion, original debt, amount for fiscal 2020 was $1.37M.
- Creative Medical Technology Holdings, Inc. debt conversion, original debt, amount for fiscal 2018 was $44.00K.
| Period end | Debt Conversion, Original Debt, Amount 3 month | Debt Conversion, Original Debt, Amount 6 month | Debt Conversion, Original Debt, Amount 6 month as first filed | Debt Conversion, Original Debt, Amount 9 month | Debt Conversion, Original Debt, Amount 12 month |
|---|---|---|---|---|---|
| 2021-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $153.98K derived: sum of 2 quarters · filed 2023-03-31 | $495.77K derived: sum of 3 quarters · filed 2023-03-31 | $1.38M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $153.98K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $495.77K derived: sum of 2 quarters · filed 2022-08-12 | $1.38M 10-Q · filed 2021-11-15 | $1.72M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-06-30 | $341.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $1.23M 10-Q · filed 2022-08-12 | $1.56M derived: sum of 3 quarters · filed 2022-08-12 | $1.99M derived: sum of 4 quarters · filed 2022-08-12 | |
| 2021-03-31 | $887.56K 10-Q · filed 2022-05-13 | $1.22M derived: sum of 2 quarters · filed 2022-05-13 | $1.65M derived: sum of 3 quarters · filed 2022-05-13 | $1.90M derived: sum of 4 quarters · filed 2022-05-13 | |
| 2020-12-31 | $333.29K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $761.45K derived: sum of 2 quarters · filed 2022-03-30 | $1.02M derived: sum of 3 quarters · filed 2022-03-30 | $1.37M 10-K · filed 2022-03-30 | |
| 2020-09-30 | $428.16K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | $682.87K derived: sum of 2 quarters · filed 2021-11-15 | $1.03M 10-Q · filed 2021-11-15 | ||
| 2020-06-30 | $254.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $605.25K 10-Q · filed 2021-08-16 | $614.55K 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $350.55K 10-Q · filed 2021-05-17 | ||||
| 2019-09-30 | $697.88K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $1.36M 10-Q · filed 2020-11-13 | |||
| 2019-06-30 | $660.21K 10-Q · filed 2020-08-14 | ||||
| 2018-12-31 | $44.00K 10-K · filed 2019-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Silexion Therapeutics Corp (SLXN) | $0.001B |